SOLY
Soliton, Inc.
Set alert
22.58 0.00 0.00%
22.56 Day range 22.59
52-week range unavailable
- Open
- 22.56
- Prev close
- 22.58
- Mkt cap
- 487.65M
- Vol
- 1.35M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 22.56
- High
- 22.59
- Forward P/E
- -26.26
- Beta
- 0.18
- Short ratio
- 16.27
- Inst. own
- 40.01%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 23, 2021
- 50-d avg
- 20.88
- 200-d avg
- 20.64
- 1y target
- 0.00
Key statistics
- Market cap
- 487.65M
- Enterprise value
- 465.90M
- Trailing P/E
- 0.00
- Forward P/E
- -26.26
- PEG ratio
- -0.51
- Price / sales
- 1317.97
- Price / book
- 22.83
- EPS (TTM)
- -0.84
- Beta
- 0.18
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 370.00K
- Revenue growth
- 0.00%
- Free cash flow
- -10.11M
- Total cash
- 21.75M
- Total debt
- 0
- Return on equity
- -63.97%
- Shares outstanding
- 21.60M
- Short % of float
- 14.11%
- 50-day average
- 20.88
- 200-day average
- 20.64
Analyst view
Consensus: hold
Hold
Price target (mean) 0.00
Next earnings
Dec 23, 2021
Expected Dec 23, 2021. Consensus EPS estimate -0.31.
Financials — quick view
SOLY Revenue — quarterly 370.00K
SOLY Net income — quarterly -272.00K
SOLY EPS — quarterly -0.01
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 23, 2021 | Sep 1, 2021 | -0.32 | — | — | — |
| Aug 12, 2021 | Jun 1, 2021 | -0.31 | — | — | — |
| May 12, 2021 | Mar 1, 2021 | -0.24 | — | — | — |
| Mar 4, 2021 | Dec 1, 2020 | -0.22 | — | — | — |
| Nov 12, 2020 | Sep 1, 2020 | -0.16 | — | — | — |
| Aug 11, 2020 | Jun 1, 2020 | -0.19 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 2, 2021 | Roth Capital | down | Buy | Neutral |
| May 13, 2021 | Cantor Fitzgerald | down | Overweight | Neutral |
| Jul 15, 2020 | Cantor Fitzgerald | init | — | Overweight |
About Soliton, Inc.
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- soliton.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on SOLY — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| REMEDITEX VENTURES, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jun 29, 2020 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Sio Capital Management, LLC | 3.82% | 824,803 | 16.79M | Sep 29, 2021 |
| Blackrock Inc. | 3.39% | 731,484 | 14.89M | Sep 29, 2021 |
| Vanguard Group, Inc. (The) | 2.87% | 619,757 | 12.62M | Sep 29, 2021 |
| Polar Asset Management Partners Inc. | 2.63% | 568,309 | 11.57M | Sep 29, 2021 |
| Millennium Management LLC | 2.29% | 493,596 | 10.05M | Sep 29, 2021 |
| First Trust Capital Management L.P. | 1.73% | 373,004 | 7.59M | Sep 29, 2021 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| First Tr Exchange Traded Fd-First Trust Merger Arbitrage Fd | 1.71% | 369,460 | 7.52M | Sep 29, 2021 |
| Vanguard Total Stock Market Index Fund | 1.41% | 304,169 | 6.19M | Sep 29, 2021 |
| iShares Russell 2000 ETF | 1.25% | 270,514 | 5.57M | Oct 30, 2021 |
| Vanguard Extended Market Index Fund | 0.67% | 145,636 | 2.97M | Sep 29, 2021 |
| iShares Russell 2000 Growth ETF | 0.42% | 90,337 | 1.86M | Oct 30, 2021 |
| IndexIQ Tr-IQ Merger Arbitrage ETF | 0.38% | 81,857 | 1.67M | Sep 29, 2021 |